U.S. In Vitro Diagnostics Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. In Vitro Diagnostics Market 

5.1. COVID-19 Landscape: U.S. In Vitro Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. In Vitro Diagnostics Market, By Product

8.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Product

8.1.1. Reagents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Services

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. U.S. In Vitro Diagnostics Market, By Test Location

9.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Test Location

9.1.1. Point of Care

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Home Care

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. U.S. In Vitro Diagnostics Market, By Technology 

10.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Technology

10.1.1. Immunoassay

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Hematology

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Clinical Chemistry

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Molecular Diagnostics

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Coagulation

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Microbiology

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast

Chapter 11. U.S. In Vitro Diagnostics Market, By Application

11.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by Application

11.1.1. Diabetes

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Cardiology

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Nephrology

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Infectious Disease

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Oncology

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Drug Testing

11.1.6.1. Market Revenue and Volume Forecast

11.1.7. Autoimmune Diseases

11.1.7.1. Market Revenue and Volume Forecast

11.1.8. Others

11.1.8.1. Market Revenue and Volume Forecast

Chapter 12. U.S. In Vitro Diagnostics Market, By End User

12.1. U.S. In Vitro Diagnostics Market Revenue and Volume, by End User

12.1.1. Standalone Laboratories

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Hospitals

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Academic & Medical Schools

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Point-of-Care

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Others

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. U.S. In Vitro Diagnostics Market, U.S. Estimates and Trend Forecast

13.1. U.S.

13.1.1. Market Revenue and Volume Forecast, by Product

13.1.2. Market Revenue and Volume Forecast, by Test Location

13.1.3. Market Revenue and Volume Forecast, by Technology

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Alere, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Beckman Coulter

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BD

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bio-Rad laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Danaher

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abbott Laboratories

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Thermo Fisher Scientific Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. bioMérieux, Inc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quest Diagnostics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Illumina, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms